Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 65,698,350
- Share change
- +6,981,178
- Total reported value
- $726,012,410
- Put/Call ratio
- 58%
- Price per share
- $11.05
- Number of holders
- 240
- Value change
- +$84,257,823
- Number of buys
- 106
- Number of sells
- 109
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
7.5%
|
10,029,500
|
$84,949,865 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5.8%
|
7,693,156
|
$65,161,031 | — | 30 Jun 2025 | |
| ILJIN SNT Co., Ltd. |
13D/G
|
Chin Kyu Huh |
5%
|
6,535,141
|
$57,509,241 | $0 | 11 Aug 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
4.5%
|
6,400,000
|
$51,840,000 | $0 | 31 Dec 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
3%
|
3,969,834
|
$33,624,494 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,795,090
|
$23,674,412 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
2,396,239
|
$20,296,147 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
1,720,878
|
$14,575,837 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,577,060
|
$13,355,197 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.93%
|
1,242,512
|
$10,524,077 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.87%
|
1,157,800
|
$9,806,566 | — | 30 Jun 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.81%
|
1,076,118
|
$9,114,719 | — | 30 Jun 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.7%
|
933,862
|
$7,909,812 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
921,271
|
$7,803,165 | — | 30 Jun 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.6%
|
798,758
|
$6,765,000 | — | 30 Jun 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.56%
|
748,113
|
$6,336,517 | — | 30 Jun 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.49%
|
657,835
|
$5,571,862 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.49%
|
650,191
|
$5,507,118 | — | 30 Jun 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.43%
|
565,956
|
$4,793,647 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.41%
|
550,501
|
$4,662,743 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.41%
|
547,802
|
$4,639,883 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
511,731
|
$4,334,362 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.38%
|
500,416
|
$4,238,524 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.36%
|
483,937
|
$4,098,946 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.35%
|
470,791
|
$3,987,600 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.35%
|
466,627
|
$3,952,332 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.33%
|
443,578
|
$3,757,106 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.33%
|
439,020
|
$3,718,499 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.33%
|
438,349
|
$3,712,816 | — | 30 Jun 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.3%
|
399,433
|
$3,383,198 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.29%
|
390,101
|
$3,304,155 | — | 30 Jun 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.27%
|
355,000
|
$3,116,900 | — | 30 Jun 2025 | |
| HUSSMAN STRATEGIC ADVISORS, INC. |
13F
|
Company |
0.27%
|
357,000
|
$3,023,790 | — | 30 Jun 2025 | |
| Michael Robert Martin |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
259,162
|
$2,918,164 | — | 02 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.26%
|
341,540
|
$2,892,844 | — | 30 Jun 2025 | |
| PDT Partners, LLC |
13F
|
Company |
0.25%
|
328,701
|
$2,784,097 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
325,808
|
$2,759,598 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
325,629
|
$2,758,077 | — | 30 Jun 2025 | |
| Scott Michael Habig |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
456,338
|
$2,423,155 | — | 06 Aug 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.21%
|
280,512
|
$2,375,000 | — | 30 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.21%
|
279,418
|
$2,367,000 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.2%
|
269,564
|
$2,283,207 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.2%
|
265,961
|
$2,252,690 | — | 30 Jun 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.2%
|
262,335
|
$2,221,977 | — | 30 Jun 2025 | |
| IFP Advisors, Inc |
13F
|
Company |
0.2%
|
260,034
|
$2,203,682 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
250,320
|
$2,120,210 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.18%
|
237,088
|
$2,008,138 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.18%
|
234,944
|
$1,989,976 | — | 30 Jun 2025 | |
| Volker Knappertz |
3/4/5
|
EVP, Research and Development |
—
class O/S missing
|
319,128
|
$1,946,681 | — | 27 Feb 2024 | |
| Swiss National Bank |
13F
|
Company |
0.17%
|
222,900
|
$1,887,963 | — | 30 Jun 2025 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2025
As of 30 Sep 2025,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,698,350 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., NEA Management Company, LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, STATE STREET CORP, MORGAN STANLEY, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
216
Q3 2025 holders
240
Holder diff
24
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.